94 related articles for article (PubMed ID: 15333580)
1. Telomere-based DNA damage responses: a new approach to melanoma.
Puri N; Eller MS; Byers HR; Dykstra S; Kubera J; Gilchrest BA
FASEB J; 2004 Sep; 18(12):1373-81. PubMed ID: 15333580
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.
Pitman RT; Wojdyla L; Puri N
Oncotarget; 2013 May; 4(5):761-71. PubMed ID: 23800953
[TBL] [Abstract][Full Text] [Related]
3. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.
Yaar M; Eller MS; Panova I; Kubera J; Wee LH; Cowan KH; Gilchrest BA
Breast Cancer Res; 2007; 9(1):R13. PubMed ID: 17257427
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
Li GZ; Eller MS; Hanna K; Gilchrest BA
Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
[TBL] [Abstract][Full Text] [Related]
5. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
[TBL] [Abstract][Full Text] [Related]
7. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
8. T-oligo induces apoptosis in advanced prostate cancer cells.
Gnanasekar M; Thirugnanam S; Zheng G; Chen A; Ramaswamy K
Oligonucleotides; 2009 Sep; 19(3):287-92. PubMed ID: 19642913
[TBL] [Abstract][Full Text] [Related]
9. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
10. Silencing livin gene by siRNA leads to apoptosis induction, cell cycle arrest, and proliferation inhibition in malignant melanoma LiBr cells.
Wang H; Tan SS; Wang XY; Liu DH; Yu CS; Bai ZL; He DL; Zhao J
Acta Pharmacol Sin; 2007 Dec; 28(12):1968-74. PubMed ID: 18031611
[TBL] [Abstract][Full Text] [Related]
11. Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells.
Staudt MR; Depass AL; Sarkar D; Fisher PB
J Cell Physiol; 2009 Feb; 218(2):304-14. PubMed ID: 18844238
[TBL] [Abstract][Full Text] [Related]
12. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
13. Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy.
Uppada SB; Erickson T; Wojdyla L; Moravec DN; Song Z; Cheng J; Puri N
Int J Nanomedicine; 2014; 9():43-53. PubMed ID: 24391441
[TBL] [Abstract][Full Text] [Related]
14. Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiency.
Taylor CW; Grogan TM; Lopez MH; Leong SP; Odeleye A; Feo-Zuppardi FJ; Hersh EM
Lab Invest; 1992 Jul; 67(1):130-7. PubMed ID: 1625443
[TBL] [Abstract][Full Text] [Related]
15. T-oligo as an anticancer agent in colorectal cancer.
Wojdyla L; Stone AL; Sethakorn N; Uppada SB; Devito JT; Bissonnette M; Puri N
Biochem Biophys Res Commun; 2014 Apr; 446(2):596-601. PubMed ID: 24632202
[TBL] [Abstract][Full Text] [Related]
16. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
17. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
[TBL] [Abstract][Full Text] [Related]
18. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells.
Ohashi N; Yaar M; Eller MS; Truzzi F; Gilchrest BA
J Cell Physiol; 2007 Mar; 210(3):582-95. PubMed ID: 17133364
[TBL] [Abstract][Full Text] [Related]
19. Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy K; Chehab NH; Waterman MJ; Lien MC; El-Deiry WS; Herlyn M; Halazonetis TD
Cell Growth Differ; 2000 Sep; 11(9):467-74. PubMed ID: 11007451
[TBL] [Abstract][Full Text] [Related]
20. Ircinin-1 induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells.
Choi HJ; Choi YH; Yee SB; Im E; Jung JH; Kim ND
Mol Carcinog; 2005 Nov; 44(3):162-73. PubMed ID: 16163705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]